• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓增殖性肿瘤患者的肺动脉高压:一项包含 183 例患者的大型队列研究。

Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients.

机构信息

Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, France; Aix-Marseille University, INSERM, UMR1090 TAGC, Marseille F_13288, France.

Hematology and Cellular Therapy Department, La Conception, University Hospital of Marseille, France; General Medicine Department, Aix-Marseille University, France.

出版信息

Eur J Intern Med. 2019 Oct;68:71-75. doi: 10.1016/j.ejim.2019.08.004. Epub 2019 Aug 14.

DOI:10.1016/j.ejim.2019.08.004
PMID:31421946
Abstract

BACKGROUND

Chronic myeloproliferative neoplasms (MPN) are recognized as a cause of pulmonary hypertension (pH). We ought to describe the prevalence and characteristics of PH in a cohort of MPN who were screened using transthoracic echocardiography (TTE).

METHODS

One hundred eighty-three newly diagnosed consecutive MPN patients were prospectively evaluated using TTE to detect PH.

RESULTS

Two patients were diagnosed with chronic eosinophilic leukemia, two patients had post-essential thrombocythemia (ET) myelofibrosis (MF), two patients had post-polycythemia vera (PV) MF, 11 patients had primary myelofibrosis (PMF), 28 patients had chronic myeloid leukemia (CML), 51 patients had PV, and 87 patients had ET. TTE was used to determine PH, and PH was suspected in 16 of 183 patients as follows: four with PV, seven with ET, two with PMF, and three with CML. Two patients with ET were excluded because of global cardiac failure. Three patients underwent right heart catheterization to confirm PH. The 14 (7.7%) patients with PH had no cardiac or lung disease that directly involved MPN in PH development.

CONCLUSION

In this large cohort of 183 MPN patients, TTE was used to diagnose PH, and 14 patients (7.7%) developed PH. This prevalence was lower than expected based on previously reported data, but it remains higher than in the general population.

摘要

背景

慢性骨髓增生性肿瘤(MPN)被认为是肺动脉高压(PH)的病因之一。我们应该描述一组经胸超声心动图(TTE)筛查的 MPN 患者中 PH 的患病率和特征。

方法

183 例新诊断的连续 MPN 患者前瞻性地接受 TTE 评估,以检测 PH。

结果

两名患者被诊断为慢性嗜酸性白血病,两名患者为原发性血小板增多症(ET)后骨髓纤维化(MF),两名患者为真性红细胞增多症(PV)后 MF,11 名患者为原发性骨髓纤维化(PMF),28 名患者为慢性髓性白血病(CML),51 名患者为 PV,87 名患者为 ET。TTE 用于确定 PH,183 例患者中有 16 例疑似 PH,如下所示:4 例 PV、7 例 ET、2 例 PMF 和 3 例 CML。由于全心衰竭,ET 中有 2 例患者被排除在外。有 3 例患者进行了右心导管检查以确认 PH。在 14 例(7.7%)患有 PH 的患者中,没有直接涉及 PH 发展的 MPN 的心脏或肺部疾病。

结论

在这项 183 例 MPN 患者的大型队列研究中,TTE 用于诊断 PH,14 例(7.7%)患者出现 PH。这一患病率低于先前报告的数据预期,但仍高于一般人群。

相似文献

1
Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients.骨髓增殖性肿瘤患者的肺动脉高压:一项包含 183 例患者的大型队列研究。
Eur J Intern Med. 2019 Oct;68:71-75. doi: 10.1016/j.ejim.2019.08.004. Epub 2019 Aug 14.
2
Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms.骨髓增殖性肿瘤患者肺动脉高压的频率和病因。
Eur J Haematol. 2019 Mar;102(3):227-234. doi: 10.1111/ejh.13197. Epub 2019 Jan 10.
3
Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms.慢性骨髓增生性肿瘤相关肺动脉高压的患病率和危险因素。
Eur J Haematol. 2021 Feb;106(2):250-259. doi: 10.1111/ejh.13543. Epub 2020 Nov 22.
4
Evaluation of hemodynamic parameters among patients with myeloproliferative neoplasms and suspected pulmonary hypertension.评估骨髓增殖性肿瘤伴疑似肺动脉高压患者的血液动力学参数。
Leuk Lymphoma. 2021 Jun;62(6):1458-1465. doi: 10.1080/10428194.2020.1864351. Epub 2021 Jan 25.
5
Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients.骨髓增殖性肿瘤患者超声心动图显示肺动脉高压可能性高的患病率及危险因素
Int J Hematol. 2020 Nov;112(5):631-639. doi: 10.1007/s12185-020-02952-4. Epub 2020 Jul 23.
6
Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.费城染色体阴性骨髓增殖性肿瘤的临床表现及并发症危险因素
Asian Pac J Cancer Prev. 2015;16(12):5013-8. doi: 10.7314/apjcp.2015.16.12.5013.
7
Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients.费城染色体阴性骨髓增殖性肿瘤患者的肺动脉高压:225例患者的单中心回顾性分析
Blood Res. 2020 Jun 30;55(2):77-84. doi: 10.5045/br.2020.2020001.
8
Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.与骨髓增生性肿瘤相关的肺动脉高压的临床表型和结局:一项基于人群的研究。
Am J Respir Crit Care Med. 2023 Sep 1;208(5):600-612. doi: 10.1164/rccm.202210-1941OC.
9
Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.慢性骨髓增殖性疾病患者肺动脉高压的发病率。
J Natl Med Assoc. 2006 Nov;98(11):1779-82.
10
Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.骨髓增殖性疾病诊断标准的概念变迁以及骨髓增殖性肿瘤的分子病因学与分类:从1950年的达梅谢克到2005年的万琴克尔及以后
Acta Haematol. 2015;133(1):36-51. doi: 10.1159/000358580. Epub 2014 Aug 7.

引用本文的文献

1
Transformed to myelofibrosis is a risk factor for pulmonary hypertension in Philadelphia chromosome-negative myeloproliferative neoplasms.转化为骨髓纤维化是费城染色体阴性骨髓增殖性肿瘤患者发生肺动脉高压的一个危险因素。
Ann Hematol. 2025 Apr;104(4):2279-2285. doi: 10.1007/s00277-025-06334-w. Epub 2025 Apr 21.
2
Pulmonary Hypertension in the Field of Hematological and Oncological Diseases.血液学和肿瘤学疾病领域的肺动脉高压
Respiration. 2025;104(7):466-475. doi: 10.1159/000544126. Epub 2025 Feb 12.
3
High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera.
超声心动图显示肺动脉高压风险高会缩短真性红细胞增多症患者的生存期。
Blood Adv. 2025 Mar 25;9(6):1320-1329. doi: 10.1182/bloodadvances.2024013970.
4
Thrombotic, Cardiovascular, and Microvascular Complications of Myeloproliferative Neoplasms and Clonal Hematopoiesis (CHIP): A Narrative Review.骨髓增殖性肿瘤和克隆性造血(CHIP)的血栓形成、心血管和微血管并发症:一项叙述性综述
J Clin Med. 2024 Oct 12;13(20):6084. doi: 10.3390/jcm13206084.
5
In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: Insights from the National Readmissions Database.骨髓增殖性肿瘤合并心力衰竭患者的住院及再入院结局:来自国家再入院数据库的见解
Int J Cardiol Heart Vasc. 2023 Nov 29;49:101304. doi: 10.1016/j.ijcha.2023.101304. eCollection 2023 Dec.
6
Association of polycythemia vera with non‑cirrhotic portal hypertension in five patients: A case series.五例真性红细胞增多症与非肝硬化门静脉高压症的关联:病例系列
Exp Ther Med. 2023 Feb 16;25(4):149. doi: 10.3892/etm.2023.11848. eCollection 2023 Apr.
7
Cardiovascular Disease in Myeloproliferative Neoplasms: State-of-the-Art Review.骨髓增殖性肿瘤中的心血管疾病:最新综述
JACC CardioOncol. 2022 Jun 21;4(2):166-182. doi: 10.1016/j.jaccao.2022.04.002. eCollection 2022 Jun.
8
Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils.JAK2V617F 相关克隆性造血促进肺血管高压,同时肺中性粒细胞中 ALK1 上调。
Nat Commun. 2021 Oct 26;12(1):6177. doi: 10.1038/s41467-021-26435-0.
9
Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.转化生长因子 β 介导的微力学调节原发性骨髓纤维化中的疾病进展。
J Cell Mol Med. 2020 Oct;24(19):11100-11110. doi: 10.1111/jcmm.15526. Epub 2020 Sep 5.
10
Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients.费城染色体阴性骨髓增殖性肿瘤患者的肺动脉高压:225例患者的单中心回顾性分析
Blood Res. 2020 Jun 30;55(2):77-84. doi: 10.5045/br.2020.2020001.